Red Sox prospect Brainer Bonaci receives season-long suspension
Brainer Bonaci, one of the Red Sox’s top-ranked infield prospects, will miss the entire 2024 season.
As first reported by Alex Speier of the Boston Globe, Bonaci received a season-long suspension for violating the minor-league domestic violence, sexual assault, and child abuse policy. The details of Bonaci’s violation remain under wraps.
Bonaci last played for one of their affiliates on Aug. 27. He was 16 games into a promotion to Double-A when he was quietly placed on the suspended list and sent home. In early October, he was placed on the restricted list and sent home from the Arizona Fall League after two games.
The Venezuelan middle infielder signed with the Red Sox in 2018, when he was 16 years old. MLB Pipeline last ranked him as the organization’s No. 12 prospect.
More Stories
Beyond Algorithmic Echo Chambers: The Rise of Authentic Lifestyle Communities in Europe’s Creator Economy
Europe’s social media landscape is undergoing a quiet revolution. After more than a decade of polished influencer culture, algorithmic homogenization,...
What UK SMEs Should Know About Workplace EV Charging
A workplace EV charge point used to be a perk reserved for headquartered corporates. The picture in 2026 looks different....
Apprenticeships ‘tougher to land than Oxbridge places’ as ministers pledge £600m for 60,000 new starts
In a claim that will resonate with thousands of school-leavers wading through a torrent of rejection emails this summer, the...
Farage promises tax-free overtime in £5bn pitch to working Britain
Reform UK leader vows to lift income tax from overtime pay for anyone earning under £75,000, a policy he says...
Overseas investors retreat from UK commercial property as red tape bites
Britain’s pitch as the most reliable address in European real estate has taken a knock. Foreign investors, the lifeblood of...
Alvotech founder Robert Wessman threatens to quit Britain over ‘anti-wealth’ tax regime
The Icelandic-born billionaire behind Nasdaq-listed biosimilars group Alvotech has become the latest international entrepreneur to warn that Britain’s tax direction...